Monday, December 1, 2025
Boehringer Ingelheim Appoints Harsha Deshmukh as New Executive Leader for IT and Global Business Services Effective February 2026
Boehringer Ingelheim has announced a significant change within its executive leadership: The Shareholders’ Committee has appointed Harsha Deshmukh to the Executive Leadership Team, effective February 1, 2026. In his new role, he will be responsible for IT and Global Business Services – two areas that will now operate as an independent executive division and play a central role in advancing the company’s digital evolution.
By separating these units from the former Group Functions division, Boehringer Ingelheim underscores the strategic relevance of digital innovation and modern internal service structures. Deshmukh is expected to accelerate this development and further strengthen the company’s transformation strategy.
Hubertus von Baumbach, Chairman of the Shareholders’ Committee, emphasized the importance of this decision: “With his extensive experience in driving innovation, he will further advance our transformation journey – a transformation in service of patients.” He added that the success of this journey is rooted in the proven commitment of all employees.
Shashank Deshpande, Chairman of the Board of Managing Directors, also welcomed the appointment, stating that strengthening IT and services is essential to securing the company’s future growth.
Harsha Deshmukh joins from Infineon Technologies AG in Munich, where he most recently served as Executive Vice President & Chief Information Officer. With academic qualifications in electronics, human resources, and global management and more than 35 years of professional experience, he brings comprehensive expertise in technology, digitalization, and operational transformation.
His key career milestones include:
- 2021 – present: Executive Vice President & Chief Information Officer, Infineon Technologies AG, Munich
- 2009 – 2021: Senior Vice President Information Technology, Infineon Technologies AG, Munich
- 2001 – 2009: Director of Supply Chain Applications, Infineon Technologies, Munich
- 1999 – 2001: Senior Consultant Advanced Planning Systems, Siemens Information Management Systems, Mumbai
- 1989 – 1999: Manager Manufacturing Automation, Mukand Ltd., Mumbai
With this appointment, Boehringer Ingelheim is enhancing its digital capabilities and the quality of its global internal services, sending a clear signal for long-term growth and innovation.
Related articles
Dr. Florian Block Appointed as New Managing Director at Herbaria
The Salus Group is realigning its structure: Effective January 1, 2026, Dr. Florian Block becomes the sole Managing Director of Herbaria Kräuterparadies GmbH, deepening the group's integration. After 25 years, Erwin Winkler moves to Bioland e. V. as Head of Market Management.
New Executive Duo at BAHN-BKK
BAHN-BKK is reshaping its leadership: Christine Enenkel will become CEO on January 1, 2026, while Dominik Dany joins the executive board to support the fund’s strategic development.
Cochlear strengthens product management with Dr. Delphine Lindel
Cochlear Germany introduces Dr. Delphine Lindel as a proven expert in strategic product management. The experienced healthcare specialist will immediately assume the position of Group Product Manager.
Dr. Hans-Peter Hubmann confirmed as DAPI Chairman
Dr. Hans-Peter Hubmann was unanimously confirmed as Chairman of DAPI and will continue to lead the institute for another four years.
Annika Hollmann to Head Communications at DSO
As of November 1, Annika Hollmann has taken over as Head of Communications at the German Organ Transplantation Foundation (DSO), succeeding Birgit Blome, who is retiring.
Gregor Müller becomes new Managing Director at Thieme RECOM
As of November 1, 2025, Gregor Müller has taken on the role of Managing Director at Thieme RECOM. The experienced health economist aims to advance digital transformation and expand the company’s product portfolio.
Thomas Meier becomes new CEO of Medios AG
The Supervisory Board of Medios AG has appointed Thomas Meier as CEO effective February 1, 2026. He succeeds Matthias Gaertner, who will remain in office until the end of 2025.
Dr. Johanna Graf becomes Deputy Chair of BEYOND FLUORID
Renowned dentist and author Dr. Johanna Graf becomes Deputy Chair of the Scientific Advisory Board at BEYOND FLUORID, reinforcing the initiative’s scientific independence.